Photo taken from Anita Afzali/X
Jun 8, 2024, 02:27
Anita Afzali: Ozanimod for moderate to severe ulcerative colitis
Anita Afzali, Executive Vice Chair of the University of Cincinnati College of Medicine, shared a post on X:
“Our Pub Alert – Ozanimod for moderate to severe ulcerative colitis in patients naive to advanced therapies
Take a read.”
Read further.
Source: Anita Afzali/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 14, 2024, 17:57
Nov 14, 2024, 17:46
Nov 14, 2024, 17:46
Nov 14, 2024, 17:42
Nov 14, 2024, 17:14